These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2598410)
1. 6-ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage. Gibboney DS; French BT; Patrick DE; Trewyn RW Cancer Chemother Pharmacol; 1989; 25(3):189-94. PubMed ID: 2598410 [TBL] [Abstract][Full Text] [Related]
2. Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells. French BT; Patrick DE; Grever MR; Trewyn RW Cancer Chemother Pharmacol; 1990; 27(3):171-7. PubMed ID: 2265452 [TBL] [Abstract][Full Text] [Related]
3. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells. Morgan CJ; Chawdry RN; Smith AR; Siravo-Sagraves G; Trewyn RW Cancer Res; 1994 Oct; 54(20):5387-93. PubMed ID: 7923170 [TBL] [Abstract][Full Text] [Related]
4. Guanine analog-induced differentiation of human promyelocytic leukemia cells and changes in queuine modification of tRNA. Kretz KA; Katze JR; Trewyn RW Mol Cell Biol; 1987 Oct; 7(10):3613-9. PubMed ID: 3479681 [TBL] [Abstract][Full Text] [Related]
5. Effect of 6-thioguanine on Chlamydia trachomatis growth in wild-type and hypoxanthine-guanine phosphoribosyltransferase-deficient cells. Qin B; McClarty G J Bacteriol; 1992 May; 174(9):2865-73. PubMed ID: 1569017 [TBL] [Abstract][Full Text] [Related]
6. Development of a bacterial screen for novel hypoxanthine-guanine phosphoribosyltransferase substrates. Shivashankar K; Subbayya IN; Balaram H J Mol Microbiol Biotechnol; 2001 Oct; 3(4):557-62. PubMed ID: 11545274 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the alterations in purine nucleotide metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient rat neuroma cell line. Zoref-Shani E; Bromberg Y; Brosh S; Sidi Y; Sperling O J Neurochem; 1993 Aug; 61(2):457-63. PubMed ID: 8336135 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells. Ishiguro K; Sartorelli AC Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells. Ishiguro K; Schwartz EL; Sartorelli AC J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322 [TBL] [Abstract][Full Text] [Related]
10. Induction of HL-60 leukemia cell differentiation by tetrahydrofolate inhibitors of de novo purine nucleotide biosynthesis. Sokoloski JA; Beardsley GP; Sartorelli AC Cancer Chemother Pharmacol; 1991; 28(1):39-44. PubMed ID: 2040032 [TBL] [Abstract][Full Text] [Related]
11. Biochemical basis of the prevention of 6-thiopurine toxicity by the nucleobases, hypoxanthine and adenine. Hashimoto H; Kubota M; Shimizu T; Takimoto T; Kitoh T; Akiyama Y; Mikawa H Leuk Res; 1990; 14(11-12):1061-6. PubMed ID: 2280604 [TBL] [Abstract][Full Text] [Related]
12. Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability. Knejzlík Z; Herkommerová K; Hocková D; Pichová I J Bacteriol; 2020 Feb; 202(5):. PubMed ID: 31818925 [TBL] [Abstract][Full Text] [Related]
13. Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5,10-dideazatetrahydrofolic acid (DDATHF). Sokoloski JA; Pizzorno G; Beardsley GP; Sartorelli AC Oncol Res; 1993; 5(8):293-9. PubMed ID: 8012061 [TBL] [Abstract][Full Text] [Related]
14. Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from hypoxanthine-guanine phosphoribosyltransferase-deficient transgenic mice. Pelled D; Sperling O; Zoref-Shani E J Neurochem; 1999 Mar; 72(3):1139-45. PubMed ID: 10037486 [TBL] [Abstract][Full Text] [Related]
15. Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites. Elgemeie GH Curr Pharm Des; 2003; 9(31):2627-42. PubMed ID: 14529546 [TBL] [Abstract][Full Text] [Related]
16. A comparison of purine metabolism and nucleotide pools in normal and hypoxanthine-guanine phosphoribosyltransferase-deficient neuroblastoma cells. Snyder FF; Cruikshank MK; Seegmiller JE Biochim Biophys Acta; 1978 Nov; 543(4):556-69. PubMed ID: 718989 [TBL] [Abstract][Full Text] [Related]
17. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage. Edwards NL; Recker D; Fox IH J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834 [TBL] [Abstract][Full Text] [Related]
18. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line. Lucas DL; Webster HK; Wright DG J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells. Schwartz EL; Blair OC; Sartorelli AC Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046 [TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of purine metabolism in Leishmania donovani. Hwang HY; Ullman B J Biol Chem; 1997 Aug; 272(31):19488-96. PubMed ID: 9235951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]